Healthcare & Biotech

Why An ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Buyout Is Likely After Surprisingly Strong Nuplazid Sales

By: BNL Staff - August 8, 2017 2:43 AM

Strong Nuplazid sales confirm that off label usage is very likely, thereby making Acadia Pharmaceuticals (NASDAQ:ACAD) a likely buyout opportunity.

Also posted in HADE Platform, Members, Mergers & Acquisitions

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock: Is It Too Late to Buy?

By: BNL Staff - July 21, 2017 2:43 AM

VRTX stock may have little upside, but a Gilead Sciences (NASDAQ:GILD) buyout of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) could be in play.

Also posted in HADE Platform, Hot Stocks, Members, Mergers & Acquisitions

Rite Aid Corporation Keeps Its Better Half: What’s It Mean For RAD Stock?

By: Brian Nichols - July 18, 2017 2:43 AM

Rite Aid Corporation’s pro forma disclosure of what’s left after the Walgreens deal confirms our previous conclusion, that RAD stock is a no-brainer.

Also posted in Members, Mergers & Acquisitions

Why Rite Aid Corporation (NYSE:RAD) Stock Is A No-Brainer At $2.23

By: Brian Nichols - July 13, 2017 2:43 AM

Why RAD stock presents deep value and what we expect short and long-term from Rite Aid Corporation (NYSE:RAD).

Also posted in Retail

Why Rite Aid Corporation (NYSE:RAD) Stock Is Presenting Its Best Ever Value

By: Brian Nichols - June 29, 2017 2:43 AM

RAD stock may have fallen in response to its store divestment deal with Walgreens (WBA), but rest assure Rite Aid Corporation (NYSE:RAD) got the upper hand.

Also posted in Members, Mergers & Acquisitions

The Outlook for Rite Aid Corporation (NYSE:RAD) Stock At $4 Has Not Changed!

By: Brian Nichols - June 28, 2017 2:43 AM

There is a new sense of optimism for the Walgreens (WBA) Rite Aid Corporation (NYSE:RAD) merger. Fortunately, it does not matter for RAD stock owners.

Also posted in Members, Mergers & Acquisitions